Home / Press Release / Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 2, 2025
RADNOR, Pa. — January 2, 2025 — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference.
Company management will present at 5:15PM PT on Wednesday, January 15th, 2025.
A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 30 days thereafter.
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Visit us at www.certara.com.
David Deuchler
Gilmartin Group
[email protected]
Alyssa Horowitz
[email protected]
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
